» Articles » PMID: 12077492

Mean Platelet Volume and Coronary Heart Disease in Hemodialysis Patients

Overview
Publisher Karger
Specialty Nephrology
Date 2002 Jun 22
PMID 12077492
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Mean platelet volume (MPV) has been shown to be an independent risk factor for myocardial infarction in the general population.

Methods: In the present cross-sectional study it was examined whether MPV may be associated with coronary heart disease (CHD) in patients in chronic hemodialysis treatment (n = 518). CHD was diagnosed if there was a history of myocardial infarction, coronary artery bypass grafting, or critical stenosis on coronary angiography.

Results: Mean platelet volume in hemodialysis patients was 8.22 +/- 0.06 fl. As compared with hemodialysis patients with a MPV <7.168 fl (the lower quintile limit), significantly more hemodialysis patients with a MPV >9.172 fl (the upper quintile limit) had CHD (odds ratio, 1.29; 95% confidence interval, 1.02-1.64). In a stepwise multiple logistic regression analysis MPV appeared to be an independent factor of CHD together with age, smoking, predialysis systolic blood pressure and serum triglyceride concentration. In a stepwise multiple linear regression model, MPV significantly depended on platelet count, volume of ultrafiltrate removed in one hemodialysis session, white blood cell count, treatment with beta blockers, heart rate, serum sodium and serum potassium concentrations. Additional measurements in 30 patients showed that MPV after a single hemodialysis session was not significantly different compared to predialysis values.

Conclusion: From the present study it is concluded that MPV may be associated with CHD in hemodialysis patients.

Citing Articles

Haematological Parameters in People with Atherosclerotic Cardiovascular Disease versus Those Who are Only at Risk for Cardiovascular Disease: A Comparative Cross-Sectional Study.

Abate E, Degef M, Melkie A, Gnanasekeran N, Mehdi M, Tolcha Y Diabetes Metab Syndr Obes. 2023; 16:1869-1883.

PMID: 37384132 PMC: 10296606. DOI: 10.2147/DMSO.S407480.


Evaluation of the relationship between the mean platelet volume and the neutrophil/lymphocyte ratio with progression of chronic kidney disease in patients with autosomal dominant polycystic kidney disease.

Gok M North Clin Istanb. 2022; 9(4):317-322.

PMID: 36276574 PMC: 9514079. DOI: 10.14744/nci.2021.89657.


Mean Platelet Volume: A Possible Predictor for Patients with Decompensated Chronic Heart Failure.

Andrei C, Catana A, Sinescu C, Mirica A, Ceban O, Chioncel V Int J Gen Med. 2022; 15:4131-4140.

PMID: 35465307 PMC: 9020575. DOI: 10.2147/IJGM.S362257.


The association between platelet indices and cardiovascular events in chronic kidney disease patients without dialysis.

Yu Z, Xiong J, Yang K, Huang Y, He T, Yu Y Int Urol Nephrol. 2021; 53(5):961-971.

PMID: 33387224 DOI: 10.1007/s11255-020-02696-4.


Hematological Parameters and Clinical Features in Patients with Advanced Chronic Kidney Disease.

Erken E, Ulgen C, Sarisik F, Erken N, Gungor O, Altunoren O Yonago Acta Med. 2020; 63(4):353-359.

PMID: 33253334 PMC: 7683903. DOI: 10.33160/yam.2020.11.008.